Term Name:	SLC-0111
Synonyms:	1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea, 4-(4-fluorophenylureido)-benzenesulfonamide, 4-[3-(4-fluorophenyl)ureido]benzenesulfonamide, 4-{[(4-fluorophenyl)carbamoyl]amino}benzene-1-sulfonamide, 4-{[(4-fluorophenyl)carbamoyl]amino}benzenesulfonamide, MST-104, NSC-213841, SLC 0111, SLC0111, U 104, U-104, U104, WBI-5111
Definition:	It is a potent carbonic anhydrase inhibitor (Ki = 45.1 nM and 4.5 nM for CA IX and CA XII, respectively) that is in clinical trials for the treatment of hypoxic malignancies .
Ontology:	ChEBI [CHEBI:232342]  ( EBI )